ARN-509 in men with high-risk nonmetastatic castration-resistant prostate cancer (CRPC)

被引：1
|
作者：
Smith, Matthew Raymond
Antonarakis, Emmanuel S.
Ryan, Charles J.
Berry, William R.
Shore, Neal
Liu, Glenn
Alumkal, Joshi J.
Higano, Celestia S.
Maneval, Edna Chow
Rathkopf, Dana E.
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[3] USCF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[4] US Oncol, Canc Ctr North Carolina, Raleigh, NC USA
[5] Grand Strand Urol, Myrtle Beach, SC USA
[6] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[8] Univ Washington, Sch Med, Seattle, WA USA
[9] Aragon Pharmaceut, San Diego, CA USA
[10] Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ARN-509 IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Rathkopf, D.
    Antonarakis, E. S.
    Shore, N. D.
    Tutrone, R.
    Alumkal, J.
    Ryan, C. J.
    Saleh, M.
    Hauke, R.
    Chow-Maneval, E.
    Scher, H. I.
    ANNALS OF ONCOLOGY, 2012, 23 : 317 - 317
  • [2] NOVEL ANTIANDROGEN ARN-509 IN HIGH-RISK NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Shore, Neal D.
    Antonarakis, Emmanuel S.
    Ryan, Charles J.
    Berry, William R.
    Liu, Glenn
    Higano, Celestia
    Maneval, Edna Chow
    Bandekar, Rajesh
    de Boer, Carla J.
    Todd, Mary B.
    Yu, Margaret K.
    Rathkopf, Dana E.
    Smith, Matthew R.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1090 - E1090
  • [3] ARN-509 IN MEN WITH HIGH RISK NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Smith, M. R.
    Antonarakis, E. S.
    Ryan, C. J.
    Berry, W.
    Shore, N. D.
    Liu, G.
    Alumkal, J.
    Higano, C.
    Chow-Maneval, E.
    Rathkopf, D.
    ANNALS OF ONCOLOGY, 2012, 23 : 303 - 303
  • [4] ARN-509 in men with metastatic castration-resistant prostate cancer (mCRPC)
    Rathkopf, Dana E.
    Antonarakis, Emmanuel S.
    Shore, Neal D.
    Tutrone, Ronald
    Alumkal, Joshi J.
    Ryan, Charles J.
    Saleh, Mansoor N.
    Hauke, Ralph J.
    Maneval, Edna Chow
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] ARN-509 in men with high risk non-metastatic castration-resistant prostate cancer
    Smith, M. R.
    Antonarakis, E. S.
    Ryan, C. J.
    Berry, W. R.
    Shore, N. D.
    Liu, G.
    Alumkal, J. J.
    Higano, C. S.
    Maneval, E. Chow
    Rathkopf, D. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S695 - S695
  • [6] ARN-509 IS SAFE AND EFFECTIVE IN CASTRATION-RESISTANT PROSTATE CANCER
    不详
    CANCER DISCOVERY, 2013, 3 (10) : 1093 - 1093
  • [7] A phase II study of the androgen signaling inhibitor ARN-509 in patients with castration-resistant prostate cancer (CRPC)
    Rathkopf, Dana E.
    Shore, Neal
    Antonarakis, Emmanuel S.
    Berry, William R.
    Alumkal, Joshi J.
    Tutrone, Ronald
    Saleh, Mansoor N.
    Redfern, Charles H.
    Hauke, Ralph J.
    Liu, Glenn
    Steinbrecher, Jill Elise
    Danila, Daniel Costin
    Curley, Tracy
    Arauz, Gabrielle
    Rix, Peter J.
    Maneval, Edna Chow
    Chen, Isan
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Denosumab in men with nonmetastatic castration-resistant prostate cancer (CRPC) at high risk for bone metastases
    Smith, M. R.
    Fizazi, K.
    Miller, K.
    Egerdie, B.
    Morote, J.
    Tammela, T. L.
    Wong, S.
    Ye, Z.
    Braun, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S682 - S682
  • [9] Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort
    Smith, Matthew R.
    Antonarakis, Emmanuel S.
    Ryan, Charles J.
    Berry, William R.
    Shore, Neal D.
    Liu, Glenn
    Alumkal, Joshi J.
    Higano, Celestia S.
    Maneval, Edna Chow
    Bandekar, Rajesh
    de Boer, Carla J.
    Yu, Margaret K.
    Rathkopf, Dana E.
    EUROPEAN UROLOGY, 2016, 70 (06) : 963 - 970
  • [10] Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer
    Rathkopf, Dana E.
    Morris, Michael J.
    Fox, Josef J.
    Danila, Daniel C.
    Slovin, Susan F.
    Hager, Jeffrey H.
    Rix, Peter J.
    Maneval, Edna Chow
    Chen, Isan
    Goenen, Mithat
    Fleisher, Martin
    Larson, Steven M.
    Sawyers, Charles L.
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (28) : 3525 - +
12345